EP3696163A4 - Novel pseudoceramide compound and use thereof - Google Patents

Novel pseudoceramide compound and use thereof Download PDF

Info

Publication number
EP3696163A4
EP3696163A4 EP17928505.1A EP17928505A EP3696163A4 EP 3696163 A4 EP3696163 A4 EP 3696163A4 EP 17928505 A EP17928505 A EP 17928505A EP 3696163 A4 EP3696163 A4 EP 3696163A4
Authority
EP
European Patent Office
Prior art keywords
pseudoceramide compound
novel pseudoceramide
novel
compound
pseudoceramide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17928505.1A
Other languages
German (de)
French (fr)
Other versions
EP3696163A1 (en
EP3696163B1 (en
EP3696163C0 (en
Inventor
Jin Oh Park
Ji Won Lee
Seong Hyeon Jeon
Jae Young Lee
Hye Ja Lee
Bo Kyung Kwon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daebong LS Co Ltd
Original Assignee
Daebong LS Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daebong LS Co Ltd filed Critical Daebong LS Co Ltd
Publication of EP3696163A1 publication Critical patent/EP3696163A1/en
Publication of EP3696163A4 publication Critical patent/EP3696163A4/en
Application granted granted Critical
Publication of EP3696163B1 publication Critical patent/EP3696163B1/en
Publication of EP3696163C0 publication Critical patent/EP3696163C0/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
EP17928505.1A 2017-10-11 2017-11-22 Novel pseudoceramide compound and use thereof Active EP3696163B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170131556A KR102012012B1 (en) 2017-10-11 2017-10-11 Novel pseudoceramide compounds, and the use of the same
PCT/KR2017/013381 WO2019074158A1 (en) 2017-10-11 2017-11-22 Novel pseudoceramide compound and use thereof

Publications (4)

Publication Number Publication Date
EP3696163A1 EP3696163A1 (en) 2020-08-19
EP3696163A4 true EP3696163A4 (en) 2021-06-30
EP3696163B1 EP3696163B1 (en) 2023-07-19
EP3696163C0 EP3696163C0 (en) 2023-07-19

Family

ID=66100757

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17928505.1A Active EP3696163B1 (en) 2017-10-11 2017-11-22 Novel pseudoceramide compound and use thereof

Country Status (6)

Country Link
US (1) US11471390B2 (en)
EP (1) EP3696163B1 (en)
KR (1) KR102012012B1 (en)
CN (1) CN111201216B (en)
ES (1) ES2955135T3 (en)
WO (1) WO2019074158A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102309003B1 (en) * 2019-07-29 2021-10-06 김경원 Cementation heat treatment method for steel and manufactured steel by the same
KR102137381B1 (en) * 2020-03-13 2020-07-24 (주)네오팜 Cosmetics composition containing amide compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980053300A (en) * 1996-12-26 1998-09-25 이능희 Ceramide-like compound and preparation method thereof
US6410597B1 (en) * 2000-02-25 2002-06-25 Virginia Commonwealth University Hydroxyalkyl amide analogs of ceramide
KR101750238B1 (en) * 2016-04-27 2017-06-27 (주)네오팜 Compositions for anti-aging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100458701B1 (en) * 2000-10-06 2004-12-03 주식회사 웰스킨 Whitening makeup composition containing sphingolipid or sphingolipid metabolites
KR100452757B1 (en) * 2002-05-02 2004-10-12 앨트웰코스메틱 주식회사 Manufacturing Process of Skin-Care Containing Natural Ceramide, Phytosphingoshine, Colesterol and Lecithin
KR100539965B1 (en) 2002-08-29 2006-01-10 주식회사 코리아나화장품 Cosmetic Composition Comprising Novel Pseudo Ceramide for Preventing and Alleviating Atopic Dermatitis
KR102644587B1 (en) 2015-12-24 2024-03-07 (주)아모레퍼시픽 Pseudoceramide compounds and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980053300A (en) * 1996-12-26 1998-09-25 이능희 Ceramide-like compound and preparation method thereof
US6410597B1 (en) * 2000-02-25 2002-06-25 Virginia Commonwealth University Hydroxyalkyl amide analogs of ceramide
KR101750238B1 (en) * 2016-04-27 2017-06-27 (주)네오팜 Compositions for anti-aging

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COUTURIER L ET AL: "Lipase-catalyzed chemoselective aminolysis of various aminoalcohols with fatty acids", JOURNAL OF MOLECULAR CATALYSIS B : ENZYMATIC,, vol. 56, no. 1, 1 January 2009 (2009-01-01), pages 29 - 33, XP025675113, ISSN: 1381-1177, [retrieved on 20080430], DOI: 10.1016/J.MOLCATB.2008.04.010 *
HUGO TREMBLAY ET AL: "One-pot synthesis of polyunsaturated fatty acid amides with anti-proliferative properties", BIORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 24, no. 24, 1 November 2014 (2014-11-01), Amsterdam , NL, pages 5635 - 5638, XP055237005, ISSN: 0960-894X, DOI: 10.1016/j.bmcl.2014.10.084 *

Also Published As

Publication number Publication date
US11471390B2 (en) 2022-10-18
EP3696163A1 (en) 2020-08-19
CN111201216B (en) 2023-04-28
CN111201216A (en) 2020-05-26
EP3696163B1 (en) 2023-07-19
EP3696163C0 (en) 2023-07-19
KR102012012B1 (en) 2019-08-19
WO2019074158A1 (en) 2019-04-18
KR20190040795A (en) 2019-04-19
ES2955135T3 (en) 2023-11-28
US20200330350A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
EP3383916A4 (en) Anti-cd73 antibodies and uses thereof
EP3681888A4 (en) Pyrazolopyrimidinone compounds and uses thereof
EP3625263A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3504243A4 (en) Anti-tim-3 antibodies and use thereof
EP3508580A4 (en) Novel promoter and use thereof
EP3596119A4 (en) Anti-phf-tau antibodies and uses thereof
EP3389702A4 (en) Anti-lag-3 antibodies and uses thereof
EP3501509A4 (en) Novel nanocage and use thereof
EP3453401A4 (en) Interleukin combination and use thereof
EP3248005A4 (en) Novel glycan conjugates and methods of use thereof
EP3511407A4 (en) Christensenella intestinihominis and application thereof
EP3838900A4 (en) 3-aryloxy-3-aryl-propylamine compound and uses thereof
EP3645563A4 (en) Anti-fam19a5 antibodies and uses thereof
EP3672987A4 (en) Anti-apelin antibodies and uses thereof
EP3587420A4 (en) Tri-cycle compound and applications thereof
EP3700934A4 (en) Compounds and uses thereof
EP3247365A4 (en) Novel iodophor composition and methods of use
EP3675898A4 (en) Anti-lag-3 antibodies and uses thereof
EP3658185A4 (en) Anti-tim-3 antibodies and uses thereof
EP3368011A4 (en) Novel compounds and uses thereof
EP3609504A4 (en) Novel oxaborole analogs and uses thereof
EP3681912A4 (en) Axl-specific antibodies and uses thereof
EP3638299A4 (en) Anti-l1-cam antibodies and uses thereof
EP3590929A4 (en) Spiro compound and use thereof
EP3683303A4 (en) Megamonas funiformis and applications thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200507

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210602

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 235/28 20060101AFI20210527BHEP

Ipc: C07C 231/02 20060101ALI20210527BHEP

Ipc: A61K 8/68 20060101ALI20210527BHEP

Ipc: A61Q 19/00 20060101ALI20210527BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230418

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017071667

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20230818

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20230824

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2955135

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20231128

U20 Renewal fee paid [unitary effect]

Year of fee payment: 7

Effective date: 20231113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231020

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231215

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231019

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231119

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231020

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719